Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 02023R1581-20230821

Consolidated text: Commission Implementing Regulation (EU) 2023/1581 of 1 August 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food astaxanthin-rich oleoresin from Haematococcus pluvialis algae (Text with EEA relevance)Text with EEA relevance

Access initial legal act
(

Legal status of the document In force

)

ELI: http://data.europa.eu/eli/reg_impl/2023/1581/2023-08-21

Date of document:
21/08/2023
Date of effect:
21/08/2023
Author:
Not available
Form:
Consolidated text
Link
Link
Link
Select all documents mentioning this document
Consolidation: basic act:
32023R1581

02023R1581 — EN — 21.08.2023 — 001.001

This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION IMPLEMENTING REGULATION (EU) 2023/1581

of 1 August 2023

amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food ‘astaxanthin-rich oleoresin from Haematococcus pluvialis algae’

(Text with EEA relevance)

(OJ L 194 2.8.2023, p. 4)

Amended by:

 

 

Official Journal

  No

page

date

►M1

COMMISSION IMPLEMENTING REGULATION (EU) 2023/2852 of 20 December 2023

  L 

1

21.12.2023



▼B

COMMISSION IMPLEMENTING REGULATION (EU) 2023/1581

of 1 August 2023

amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food ‘astaxanthin-rich oleoresin from Haematococcus pluvialis algae’

(Text with EEA relevance)



Article 1

The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

▼M1

Article 2

Food supplements containing ≤ 8,0 mg astaxanthin intended for the general population older than 14 years of age, complying with the requirements of Implementing Regulation (EU) 2021/1377 may continue to be placed on the market until 1 February 2024 and may be marketed until their date of minimum durability or use by date.

▼B

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.



ANNEX

In the Annex to Implementing Regulation (EU) 2017/2470, the entry for ‘Astaxanthin-rich oleoresin from Haematococcus pluvialis algae’ in Table 1 (Authorised novel foods) is replaced by the following:



Authorised novel food

Conditions under which the novel food may be used

Additional specific labelling requirements

Other requirements

‘Astaxanthin-rich oleoresin from Haematococcus pluvialis algae

Specified food category

Maximum levels of astaxanthin

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Astaxanthin rich oleoresin from Haematococcus pluvialis algae’

The labelling of food supplements containing Astaxanthin rich oleoresin from Haematococcus pluvialis algae shall bear a statement that they should not be consumed:

(a)  if other food supplements containing astaxanthin esters are consumed on the same day

(b)  by infants and young children under 3 years of age

(c)  by infants and children under 10 years of age (*1)

(d)  by infants, children and adolescents under 14 years of age (*1).

 

Food supplements as defined in Directive 2002/46/EC excluding infants and young children

2,3 mg astaxanthin per day for children 3 to less than 10 years of age

5,7 mg astaxanthin per day for adolescents 10 to less than 14 years of age

8 mg astaxanthin per day for general population older than 14 years of age
(*1)   

Depending on the age group the food supplement is intended for.’
Top